Analysis of TCGA data showed that TRPM2, among the TRP genes, was the only one whose expression was significantly increased in human lung adenocarcinomas (LUAD) compared with normal tissues (Figure S1A,B, Supporting Information) and its high expression was significantly associated with the poor survival of patients with EGFRm NSCLC (Figure S1C, Supporting Information). This evidence concerns the gene TRPM2 and lung adenocarcinoma.